Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Invested Capital (2018 - 2025)

Viemed Healthcare's Invested Capital history spans 8 years, with the latest figure at $144.6 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 9.72% year-over-year to $144.6 million; the TTM value through Dec 2025 reached $144.6 million, up 9.72%, while the annual FY2025 figure was $144.6 million, 9.72% up from the prior year.
  • Invested Capital reached $144.6 million in Q4 2025 per VMD's latest filing, up from $137.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $144.6 million in Q4 2025 to a low of $90.6 million in Q1 2021.
  • Average Invested Capital over 5 years is $113.1 million, with a median of $106.8 million recorded in 2023.
  • Peak YoY movement for Invested Capital: soared 56.89% in 2021, then fell 3.49% in 2022.
  • A 5-year view of Invested Capital shows it stood at $100.6 million in 2021, then dropped by 3.49% to $97.1 million in 2022, then rose by 18.41% to $115.0 million in 2023, then grew by 14.64% to $131.8 million in 2024, then increased by 9.72% to $144.6 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Invested Capital are $144.6 million (Q4 2025), $137.0 million (Q3 2025), and $142.4 million (Q2 2025).